Discovery of a Pharmacologically Active Antagonist of the Two-Pore-Domain Potassium Channel K2P9.1 (TASK-3)

A Specific Two-pore Domain Potassium Channel Blocker Defines the Structure of the TASK-1 Open Pore

(2011) Anne K. Streit et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist

(2011) Christopher J. Winrow et al.   JOURNAL OF NEUROGENETICS

From the Background to the Spotlight: TASK Channels in Pathological Conditions

(2010) Stefan Bittner et al.   BRAIN PATHOLOGY

Molecular Background of Leak K+ Currents: Two-Pore Domain Potassium Channels

(2010) Péter Enyedi et al.   PHYSIOLOGICAL REVIEWS

An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action

(2009) D. S. J. Pang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact

(2008) Douglas A. Bayliss et al.   TRENDS IN PHARMACOLOGICAL SCIENCES